First-of-its-kind, automated system delivers increased sensitivity, specific identification of disease markers and improved laboratory workflow to support fast, confident diagnoses WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced 510(k) clearance of the EXENT® Analyser and Immunoglobulin Isotypes (GAM) Assay**, a first-of-its-kind automated platform for clinical laboratories. [...]

BOSTON -- Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, to launch and co-market MSK-ACCESS® and MSK-IMPACT® powered with SOPHiA DDM™ on Complete Genomics' DNBSEQ-T1+ sequencing platform. The companies aim to broaden access to precision oncology testing by offering the best-in-class liquid biopsy [...]

Drives efficiency and reliability in Quality Control and Development environments, integrating seamlessly with world-class Empower™ Chromatography Data System (CDS). Mitigates CDS communication errors encountered in up to 70% of multi-vendor LC-CAD configurations.1 Delivers near-universal detection of an expansive range of analytes across pharmaceutical formulations, food additives, and environmental pollutants, including those that are challenging to measure using [...]

Schlieren, Switzerland -- InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed the definitive agreement to acquire DOPPL SA, a Lausanne-based innovator in the organoid space, including the Sun Bioscience Gri3D® technology. The acquisition strengthens InSphero’s position as the most comprehensive provider of advanced 3D in vitro models, combining scalable spheroid and organoid technologies with integrated assay [...]

Oxford Nanopore Technologies today announced that Rosemary Sinclair Dokos has been appointed as Chief Product and Marketing Officer and Dr Lakmal Jayasinghe has been appointed as Chief Scientific Officer, effective immediately. Rosemary and Lakmal succeed Clive Brown, Chief Officer of Technology, Innovation, and Products, who has stepped down to pursue new projects. Clive will be [...]

Framingham, MA – Ensorcell, the newest company to emerge from Re:Build Manufacturing, has officially launched operations in Framingham, Massachusetts. Ensorcell evaluates critical research and bioprocess technologies to develop innovative, intuitive and cost-effective solutions. Research, development and manufacturing are all United States-based, drawing from the vast network of cross-sector engineering and operations expertise in the Re:Build Manufacturing ecosystem. “At Re:Build [...]

CAPE TOWN, South Africa -- MGI Tech Co., Ltd., a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced two historic milestones in African genomics: the official unveiling of the continent's first DNBSEQ-T7 sequencing platform at the South African Medical Research Council (SAMRC), and the signing of a Memorandum [...]

mzio GmbH and Bright Giant GmbH announce a new integration between mzmine and SIRIUS. This collaboration enables researchers to launch SIRIUS analysis directly from mzmine feature tables, automating result handling and eliminating the need for manual data transfer to streamline small molecule discovery workflows. Bremen, Germany and Jena, Germany – mzio GmbH, the company behind the [...]

PreOmics Launches New Plasma Proteomics Solution P2-iST and Announces the Formation of Biognosys Group • P2-iST Plasma Launch: The new nanoparticle-based plasma proteomics workflow combines Biognosys’ P2 Plasma Enrichment with PreOmics’ iST technology, achieving identification of nearly 6,000 plasma proteins with >90% data completeness, exceptional precision, and scalability up to 192 samples processed per day. [...]

LONDON -- SMi Systems, a leading innovator in single-molecule detection for drug discovery and diagnostics, announces the appointment of Ron Andrews, Founder and Managing Partner of Bethesda Group Advisors, to its Board of Directors as a Non-Executive Director. During more than 35 years of strategic leadership in the Life Sciences Tools and Molecular Diagnostics sectors, Mr Andrews [...]